In this seminar paper I want to discuss about IBM’s efforts in the biotechnology and nanotechnology sector. As the lecture international management designated I will coin these efforts with strategies of market entry within Germany. I have chosen IBM, a US-based company, because it is highly involved in building future technologies. The Company is well known for its activities around the world and sees itself as a globally integrated enterprise. However, cultural attitudes of different countries still determine the success or failure of market entries. Germany is known as a technology-leading country. Also dealing with powerful NGO’s the success of new market entry with modern technology might seems less predictable .
In the first part of this paper I give a brief description about IBM, its research fields related to the topic and outline four research examples. Followed by an introduc-tion of Germany’s cultural attitude to bio- and nanotechnology I provide some strategic suggestions on how IBM could manage the expansion of its efforts within the targeted country.
Table of Contents
1. Introduction
2. About IBM Research
2.1 IBM’s efforts in biotechnology
2.2 Nanotechnology & nanoscience
2.3 DNA-sequencing and beyond
2.4 Computational biology research
2.5 Lab-on-a-chip
3. Germany’s attitude to bio- and nanotechnology
3.1 Biotechnology
3.2 Nanotechnology
4. Conclusion and recommendations for market entry strategies
4.1 Nanotechnology & nanoscience
4.2 DNA-sequencing and beyond
4.3 Computational biology research
4.4 Lab-on-a-chip
Research Objectives and Core Themes
The primary objective of this seminar paper is to analyze IBM's research initiatives within the biotechnology and nanotechnology sectors and to evaluate potential market entry strategies specifically tailored for the German market, considering its unique cultural and regulatory environment.
- Overview of IBM’s global research structure and scientific focus.
- Examination of specific IBM technological developments in bio- and nanotechnology.
- Analysis of the German socio-cultural and regulatory attitude toward biotechnology.
- Assessment of the reception of nanotechnology in the German scientific and public landscape.
- Development of strategic recommendations for IBM’s market entry based on the identified cultural nuances.
Excerpt from the Paper
2.2 Nanotechnology & nanoscience
From IBM’s perspective, its nanotechnology research “aims to devise new atomic and molecular-scale structures and devices for enhancing information technologies, as well as discover and understand their scientific foundations. Leading the development of nanotechnology, IBM's scientists have made numerous breakthroughs in the study of these nano-scale technologies. In particular, carbon nanotubes and scanning probes derived from the atomic force microscope - cousin of the scanning tunneling microscope - show particular promise in enabling dramatically improved circuits and data storage devices. Research on nanoparticles leads to applications in biomedicine as well as hard disk drive storage. Photonic bandgap materials -- on-chip nanoscale structures the size of a wavelength of light -- will manipulate light as optical waveguides, splitters and routers. Research into nanomechanical information storage, such as IBM's Millipede project, continues to increase the possibilities for increased areal storage density.” Another popular project introduces the racetrack memory. Bits of information are represented by tiny magnetized sections called domain walls along the length of a nanowire. The ability to move single atoms brought IBM the Nobel Prize in physics in 1986.
Another breakthrough is the nanopattering technique showed in graphic 2. In the year of 2010 IBM created a 3D map of the earth so small that 1,000 could fit on a grain of salt. In the relief, one thousand meters of altitude correspond to roughly eight nanometers (nm). A tiny, silicon tip with a sharp apex and 100,000 times smaller than a sharpened pencil can create nanosized objects at greatly reduced cost and complexity.
Summary of Chapters
1. Introduction: Outlines the scope of IBM's biotechnology and nanotechnology activities and sets the stage for exploring market entry strategies in Germany.
2. About IBM Research: Details IBM's corporate scale, research investments, and specific technological advancements across several scientific fields.
3. Germany’s attitude to bio- and nanotechnology: Examines the differing cultural and social acceptance levels regarding biotechnology and nanotechnology within Germany.
4. Conclusion and recommendations for market entry strategies: Provides actionable strategic advice for IBM by aligning its research outputs with the German market's socio-cultural requirements.
Keywords
IBM Research, Biotechnology, Nanotechnology, Germany, Market Entry, Bio-partnering, DNA-sequencing, Computational Biology, Lab-on-a-chip, Racetrack Memory, Nanopatterning, Socio-cultural Attitude, Innovation Management, Personalized Medicine, Biosafety Regulation.
Frequently Asked Questions
What is the fundamental focus of this seminar paper?
The paper examines IBM's research developments in the fields of biotechnology and nanotechnology and investigates how these technologies can be strategically introduced to the German market.
What are the central thematic areas of the research?
The main themes include the state of IBM's current research in bio- and nanotech, and an analysis of the German public and cultural environment regarding these high-tech sectors.
What is the primary goal of the study?
The goal is to formulate specific market entry strategies for IBM by identifying the opportunities and risks inherent in the German cultural landscape.
Which methodology is applied in this work?
The author utilizes a descriptive and analytical approach, combining internal IBM research documentation with external socio-cultural studies and market analysis of the German tech environment.
What topics are covered in the main section of the paper?
The main section covers IBM’s specific R&D examples (nanotech, DNA-sequencing, computational biology, lab-on-a-chip) and evaluates Germany’s specific attitudes towards these fields.
Which keywords best describe this research?
Key terms include IBM Research, Biotechnology, Nanotechnology, Germany, Market Entry, and socio-cultural attitude assessment.
How does the German attitude toward biotechnology differ from its view on nanotechnology?
The research concludes that while biotechnology faces significant cultural resistance, ethical debates, and restrictive regulations in Germany, nanotechnology is viewed more favorably and is actively supported by government programs.
What role do NGOs play in the adoption of new technologies in Germany?
NGOs act as significant influencers in the public debate; the paper notes that their entrenched positions, particularly regarding biotechnology, create challenges for foreign companies entering the market.
Why is the "Lab-on-a-chip" technology considered a lower-risk entry for IBM?
It is viewed as a high-utility, B2B medical tool that leverages technical expertise in silicon fabrication without provoking the same ethical concerns or public backlash as GMOs or broader biotechnology projects.
- Quote paper
- Daniel Bartel (Author), 2011, Analysis of the bio- and nano-technological market of Germany to find market entry strategies for chosen IBM Research Developments, Munich, GRIN Verlag, https://www.hausarbeiten.de/document/166365
